Download PDF
Semin Respir Crit Care Med 2001; 22(3): 317-326
DOI: 10.1055/s-2001-15788
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Ventilator-Associated Pneumonia Complicating the Acute Respiratory Distress Syndrome

Manuel G. Iregui, Marin H. Kollef
  • Pulmonary and Critical Care Division, Washington University School of Medicine, Saint Louis, Missouri
Further Information

Publication History

Publication Date:
31 December 2001 (online)

    Permissions and Reprints

ABSTRACT

Pulmonary infections span a wide spectrum, ranging from self-limited processes (e.g., tracheobronchitis) to life-threatening infections including both community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). Together, pneumonia and influenza rank as the sixth leading cause of death in the United States and lead all other infectious diseases in this respect.[1] Pneumonia is the second-most-common hospital-acquired infection in the United States, accounting for 17.8% of all hospital-acquired infections and 40,000 to 70,000 deaths per year.[2] HAP is the most common nosocomial infection occurring in patients requiring mechanical ventilation, developing in 6.5% of patients after 10 days and in 28% of patients after 30 days of ventilatory support.[3] Patients acquiring HAP have a greater risk of mortality than comparably ill ventilated patients who do not develop pneumonia.[2] [4] [5] Ventilator-associated pneumonia (VAP) specifically refers to a bacterial pneumonia developing in patients with acute respiratory failure who have been receiving mechanical ventilation for at least 48 hours.[5] The etiologic bacteriologic agents associated with VAP typically differ based on the timing of the occurrence of the infection relative to the start of mechanical ventilation. VAP occurring within 96 hours of the onset of mechanical ventilation is usually due to antibiotic-sensitive bacteria that colonize the patient prior to hospital admission (e.g., Streptococcus pneumoniae, Haemophilus influenza, oxacillin-sensitive Staphylococcus aureus).[6] VAP developing after 96 hours of ventilatory support is more often associated with antibiotic-resistant bacteria including oxacillin-resistant Staphylococcus aureus, Acinetobacter species and Pseudomonas aeruginosa. However, more recent data suggest that hospitalization and exposure to antibiotics prior to the start of mechanical ventilation are important risk factors for the occurrence of VAP attributed to antibiotic-resistant bacteria.[7] [8] Therefore, these risk factors should be considered when deciding on an appropriate empiric antibiotic regimen regardless of the onset of VAP. VAP and catheter-associated bloodstream infections are the leading causes of infection acquired in the intensive care unit (ICU) setting.[3] Patients in the ICU have rates of HAP that are as much as five to ten times higher than the rates in general hospital wards.[9] Additionally, like nosocomial bloodstream infections, VAP is associated with an attributable mortality beyond that accounted for by patients' severity of illness.[8] [10] The attributable mortality associated with VAP appears to be greatest for ``high-risk'' antibiotic-resistant bacteria including Pseudomonas aeruginosa and oxacillin-resistant Staphylococcus aureus. [10] [11] [12] The greater hospital mortality associated with these ``high-risk'' pathogens has been attributed to the virulence of these bacteria and the increased occurrence of inadequate initial antibiotic treatment of VAP due to the presence of antibiotic resistance.[13] This review provides an overview of the clinical importance of VAP. We then describe how this nosocomial infection influences the management and outcomes of patients with the acute respiratory distress syndrome (ARDS).

KEYWORD

Ventilator-associated pneumonia - complications - ARDS - bronchoscopy - nosocomial infection

REFERENCES

  • 1 Marston B J, Plouffe J F, File Jr M T. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio.  Arch Intern Med . 1997;  157 1709
    CrossrefPubMedGoogle Scholar
  • 2 Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention.  Morbidity & Mortality Weekly Report . 1997;  46 1-79
    PubMedGoogle Scholar
  • 3 Richards M J, Edwards J R, Culver D H, Gaynes R P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.  Crit Care Med . 1999;  27 887-892
    CrossrefPubMedGoogle Scholar
  • 4 Garcia-Garmendia J L, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez F J, Monterrubio-Villar J, Gili-Miner M. Mortality and increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.  Crit Care Med . 1999;  27 1794-1799
    PubMedGoogle Scholar
  • 5 Meduri G U. Diagnosis and differential diagnosis of ventilator-associated pneumonia.  Clinics in Chest Medicine . 1995;  16 61-93
    PubMedGoogle Scholar
  • 6 Kollef M H. Antimicrobial therapy of ventilator-associated pneumonia: how to select an appropriate drug regimen.  Chest . 1999;  115 8-11
    CrossrefPubMedGoogle Scholar
  • 7 Trouillet J L, Chastre J, Vuagnat A. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.  Am J Respir Crit Care Med . 1998;  157 531-539
    CrossrefPubMedGoogle Scholar
  • 8 Ibrahim E H, Ward S, Sherman G, Kollef M H. A comparative analysis of patients with early-onset versus late-onset nosocomial pneumonia (NP) in the ICU setting.  Chest . 2000;  117 1434-1442
    CrossrefPubMedGoogle Scholar
  • 9 Fagon J Y, Chastre J. Nosocomial pneumonia. In: Shoemaker WC, Ayres S, Grenrik A, et al Textbook of Critical Care Philadelphia, Pa: WB Saunders; 2000: 1572-1598
    Google Scholar
  • 10 Fagon J Y, Chastre J, Hance A J, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay.  Am J Med . 1993;  94 281-288
    CrossrefPubMedGoogle Scholar
  • 11 Rello J, Torres A, Ricart M. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes.  Am J Respir Crit Care Med . 1994;  150 1545-1549
    CrossrefPubMedGoogle Scholar
  • 12 Pennington J E. Nosocomial respiratory infection. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases 3rd ed. New York: Churchill Livingstone 1990: 2199-2205
    Google Scholar
  • 13 Kollef M H, Fraser V J. Antibiotic resistance in the intensive care unit.  Ann Intern Med . 2001;  134 298-314
    PubMedGoogle Scholar
  • 14 Laforce F M. Hospital-acquired gram-negative rod pneumonias: an overview.  Am J Med . 1981;  70 664-669
    CrossrefPubMedGoogle Scholar
  • 15 Levison M E, Kaye D. Pneumonia caused by gram-negative bacilli: an overview.  Rev Infect Dis . 1985;  7 S656-665
    PubMedGoogle Scholar
  • 16 Horan T C, White J W, Jarvis W R. Nosocomial infection surveillance.  MMWR . 1986;  35 175S-195S
    PubMedGoogle Scholar
  • 17 Celis R, Torres A, Gatell J M, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia. A multivariate analysis of risk and prognosis.  Chest . 1988;  93 318-324
    PubMedGoogle Scholar
  • 18 Vincent J L, Bihari D J, Suter P M. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study; EPIC International Advisory Committee.  JAMA . 1995;  274 639-644
    CrossrefPubMedGoogle Scholar
  • 19 Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units: results from a multicenter prospective study on 996 patients.  Intensive Care Medicine . 1993;  19 256-264
    CrossrefPubMedGoogle Scholar
  • 20 Langer T, Mosconi P, Cigada M, Mandelli M. Long-term respiratory support and the risk of pneumonia in critically ill patients.  Am Rev Respir Dis . 1987;  140 302-305
    PubMedGoogle Scholar
  • 21 Prod'hom G, Leuenberger P, Koerfer J. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate prophylaxis for stress ulcer: a randomized controlled trial.  Ann Intern Med . 1994;  120 653-662
    PubMedGoogle Scholar
  • 22 Craven D E, Steger K A, Barber T W. Preventing nosocomial pneumonia; state of the art and perspectives for the 1990s.  Am J Med . 1991;  91 44S-53S
    CrossrefPubMedGoogle Scholar
  • 23 Leu H S, Kaiser D L, Mori M, Woolson R F, Wenzel R P. Hospital-acquired pneumonia: attributable mortality and morbidity.  Am J Epidemiol . 1989;  129 1258-1267
    PubMedGoogle Scholar
  • 24 Niederman M S, Craven D E, Fein A M, Schultz D E. Pneumonia in the critically ill hospitalized patient.  Chest . 1990;  97 170-181
    PubMedGoogle Scholar
  • 25 Jarvis W R, Martone W J. Predominant pathogens in hospital infections.  J Antimicrob Chemother . 1992;  29(A) 19-24
    PubMedGoogle Scholar
  • 26 Marik P E, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study.  Chest . 1999;  115 178-183
    CrossrefPubMedGoogle Scholar
  • 27 Dore P, Robert R, Grollier G. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush.  Am J Respir Crit Care Med . 1996;  153 1292-1298
    PubMedGoogle Scholar
  • 28 Fink M P, Snydman D R, Niederman M S. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastin.  Antimicrobial Agents & Chemotherapy . 1994;  38 547-557
    CrossrefPubMedGoogle Scholar
  • 29 Fiddian-Green R G, Baker S. Nosocomial pneumonia in the critically ill: product of aspiration or translocation?.  Crit Care Med . 1991;  1A 763-769
    PubMedGoogle Scholar
  • 30 Huxley E J, Viroslav J, Gray W R. Pharyngeal aspiration in normal adults and patients with depressed consciousness.  Am J Med . 1978;  64 564-568
    CrossrefPubMedGoogle Scholar
  • 31 Baker A M, Meredith J A, Haponik E F. Pneumonia in intubated trauma patients: microbiology and outcomes.  Am J Respir Crit Care Med . 1996;  153 343-349
    PubMedGoogle Scholar
  • 32 Antonelli M, Moro M L, Capelli O. Risk factors for early onset pneumonia in trauma patients.  Chest . 1994;  105 224-229
    PubMedGoogle Scholar
  • 33 Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.  Chest . 1993;  104 1230-1235
    CrossrefPubMedGoogle Scholar
  • 34 Craven D E, Kunches L M, Kilinski V, Lichtenberg D A, Make B J, McCabe W R. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation.  Am Rev Respir Dis . 1986;  133 792-796
    PubMedGoogle Scholar
  • 35 Torres A, Aznar R, Gatell J M. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients.  Am Rev Respir Dis . 1990;  142 523-528
    CrossrefPubMedGoogle Scholar
  • 36 Kollef M H. Ventilator-associated pneumonia: a multivariate analysis.  JAMA . 1993;  270 1965-1970
    PubMedGoogle Scholar
  • 37 Rello J, Ausina V, Ricart M. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia.  Intensive Care Med . 1994;  20 193-198
    CrossrefPubMedGoogle Scholar
  • 38 Elatrous S, Bouydaria R, Merghli S. Incidence and risk factors of ventilator-associated pneumonia: a one-year prospective survey.  Clin Intensive Care . 1996;  7 276-281
    PubMedGoogle Scholar
  • 39 Rello J, Sonora R, Jubert P, Artigas A, Rue M, Valles J. Pneumonia in intubated patients: role of respiratory airway care.  Am J Respir Crit Care Med . 1996;  154 111-115
    CrossrefPubMedGoogle Scholar
  • 40 Baraibar J, Correa H, Mariscal D, Gallego M, Valles J, Rello J. Risk factors for infection by Acinetobacter baumanii in intubated patients with nosocomial pneumonia.  Chest . 1997;  112 1050-1054
    CrossrefPubMedGoogle Scholar
  • 41 Kollef M H, Von Harz B, Prentice D, Shapiro S D, Silver P, St. John R. Patient transport out of the intensive care unit setting increases the risk of developing ventilator-associated pneumonia.  Chest . 1997;  112 765-773
    CrossrefPubMedGoogle Scholar
  • 42 Ruiz M, Torres A, Ewig S. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome.  Am J Respir Crit Care Med . 2000;  162 119-125
    CrossrefPubMedGoogle Scholar
  • 43 Sanchez-Nieto J M, Torres A, Garcia-Cordoba F. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study.  Am J Respir Crit Care Med . 1998;  157 371-376
    CrossrefPubMedGoogle Scholar
  • 44 Violan J S, Fernandez J A, Benitez A B, Cendrero J AC, de Castro R F. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia.  Crit Care Med . 2000;  28 2737-2741
    PubMedGoogle Scholar
  • 45 Fagon J Y, Chastre J, Wolff M. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial.  Ann Intern Med . 2000;  132 621-628
    PubMedGoogle Scholar
  • 46 Singh N, Rogers P, Atwood C W, Yu V. Short course empiric antibiotic therapy for pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription.  Am J Respir Crit Care Med . 2000;  162 505-511
    CrossrefPubMedGoogle Scholar
  • 47 Papazian L, Thomas P, Garbe L. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia.  Am J Respir Crit Care Med . 1995;  152 1982-1991
    CrossrefPubMedGoogle Scholar
  • 48 Bernard G R, Artigas A, Brigham K L. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination.  Am J Respir Crit Care Med . 1994;  149 818-824
    CrossrefPubMedGoogle Scholar
  • 49 Artigas A. The American-European Consensus Conference on ARDS. Part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute Respiratory Distress Syndrome.  Am J Resp Crit Care Med . 1998;  157 1332-1347
    PubMedGoogle Scholar
  • 50 Ware L B, Matthay M A. The acute respiratory distress syndrome.  N Engl J Med . 2000;  342 1334-1349
    CrossrefPubMedGoogle Scholar
  • 51 Sloane P J, Gee M H, Gotlieb J E. A multicenter registry of patients with acute respiratory distress syndrome.  Am Rev Respir Dis . 1992;  146 419-426
    PubMedGoogle Scholar
  • 52 Matthay M A. The adult respiratory distress syndrome.  Clin Chest Med . 1990;  11 575-580
    PubMedGoogle Scholar
  • 53 Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during sever acute respiratory distress syndrome: incidence and diagnosis.  Am J Resp Crit Care Med . 1997;  156 1092-1098
    PubMedGoogle Scholar
  • 54 Markowicz P, Wolff M, Djedaini K. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome-incidence, prognosis, and risk factors.  Am J Respir Crit Care Med . 2000;  161 1942-1948
    PubMedGoogle Scholar
  • 55 Meduri G U, Reddy R C, Stanley T, El-Zeky F. Pneumonia in acute respiratory distress syndrome: a prospective evaluation of bilateral bronchoscopic sampling.  Am J Resp Crit Care Med . 1998;  158 870-875
    PubMedGoogle Scholar
  • 56 Chastre J, Trouillet J L, Vuagnat A. Nosocomial pneumonia in patients with acute respiratory distress syndrome.  Am J Respir Crit Care Med . 1998;  157 1165-1172
    PubMedGoogle Scholar
  • 57 Bauer T T, Torres A. Acute respiratory distress syndrome and nosocomial pneumonia.  Thorax . 1999;  54 1036-1040
    PubMedGoogle Scholar
  • 58 Kollef M H, Silver P, Murphy D M, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality.  Chest . 1995;  108 1655-1662
    CrossrefPubMedGoogle Scholar
  • 59 Seidenfeld J J, Pohl D F, Bell R C, Harris G D, Johanson Jr G W. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome.  Am Rev Resp Dis . 1986;  134 12-16
    PubMedGoogle Scholar
  • 60 Kollef M H, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.  Chest . 1998;  113 412-420
    CrossrefPubMedGoogle Scholar
  • 61 Luna C M, Vujacich P, Niederman M S. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.  Chest . 1997;  111 676-685
    CrossrefPubMedGoogle Scholar
  • 62 Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group.  Intensive Care Med . 1996;  22 387-394
    CrossrefPubMedGoogle Scholar
  • 63 Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia.  Am J Respir Crit Care Med . 1997;  156 196-200
    PubMedGoogle Scholar
  • 64 Gruson D, Hibert G, Vargas F. Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.  Am J Respir Crit Care Med . 2000;  162 837-843
    PubMedGoogle Scholar
  • 65 Fabregas N, Torres A, El-Ebiary M. Histopathologic and microbiologic aspects of ventilator-associated.  Anesthesiology . 1996;  84 760-761
    PubMedGoogle Scholar
  • 66 Rao V K, Ritter J, Kollef M H. Utility of transbronchial biopsy in patients with acute respiratory failure: a postmortem study.  Chest . 1998;  114 549-555
    PubMedGoogle Scholar
  • 67 Sutherland K R, Steinberg K P, Maunder R J, Milberg J A, Allen D L, Hudson L D. Pulmonary infection during the acute respiratory distress syndrome.  Am J Resp Crit Care Med . 1995;  152 550-556
    PubMedGoogle Scholar
  • 68 Nahum A, Hoyt J, Schmitz L, Moody J, Shapiro R, Marini J J. Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs.  Crit Care Med . 1997;  25 1733-1743
    CrossrefPubMedGoogle Scholar
  • 69 Brower R G, Matthay M A, Morris A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.  N Engl J Med . 2000;  342 1301-1308
    CrossrefPubMedGoogle Scholar
  • 70 Amato M B, Barbas C S, Medeiros D M. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.  N Engl J Med . 1998;  338 347-354
    CrossrefPubMedGoogle Scholar
  • 71 Kollef M H. Epidemiology and risk factors for nosocomial pneumonia.  Clin Chest Med . 1999;  20 653-670
    CrossrefPubMedGoogle Scholar
      >